PCM
GOSS icon

Pinz Capital Management’s Gossamer Bio GOSS Stock Holding History

Pinz Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-84,300
Closed -$1.1M – 148
2020
Q2 		$1.1M Buy
+84,300
New +$1.06M 0.5% 92

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Pinz Capital Management's GOSS Position: Q3 2020 in Review

Pinz Capital Management sold out of Gossamer Bio (GOSS) in Q3 2020, closing a stake of 84,300 shares — an estimated $1.1M sold.

Pinz Capital Management first reported a position in GOSS in Q2 2020 and held it in 1 quarter. The position peaked at $1.1M in Q2 2020. 125 funds tracked by Wall St. Rank hold GOSS as of Q3 2020.

  • Pinz Capital Management reported no remaining Gossamer Bio position as of Q3 2020 after selling out during the quarter.
  • Pinz Capital Management sold 84,300 Gossamer Bio shares in Q3 2020, an estimated $1.1M.
  • Pinz Capital Management first reported a position in Gossamer Bio in Q2 2020 and held it in 1 quarter.
  • Pinz Capital Management's Gossamer Bio position peaked at $1.1M in Q2 2020.
  • 125 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2020.

Based on Pinz Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.